Celsion

$2.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.94%) As of 5:27 PM UTC today

Why Robinhood?

You can buy or sell Celsion and other stocks, options, and ETFs commission-free!

About CLSN

Celsion Corporation Common Stock, also called Celsion, is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ. The listed name for CLSN is Celsion Corporation Common Stock.

CEO

Michael H. Tardugno

Employees

Headquarters

Lawrenceville, New Jersey

Founded

1982

Market Cap

130.79M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

44.57M

High Today

$2.19

Low Today

$2.03

Open Price

$2.12

Volume

3.13M

52 Week High

$6.50

52 Week Low

$0.4305

CLSN Earnings

-$0.32

-$0.21

-$0.11

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 24, Pre-Market